← All trials
NCT01623154
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2012
- Primary completion
- Mar 31, 2013
- Completion date
- Apr 30, 2013
- First posted
- Jun 19, 2012
- Last posted
- Feb 23, 2015
- Enrollment
- 99
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- OtsukaLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.